The research by the Center of Infection and Immunity of Columbia University of New York confirms that CoviSelf is able to detect the highly contagious SARS-CoV-2 B.1.1.529 variant
A recent study conducted by researchers at the Columbia University, USA shows that CoviSelf successfully detects the Omicron variant.
The research by the Center of Infection and Immunity of Columbia University of New York confirms that CoviSelf is able to detect the highly contagious SARS-CoV-2 B.1.1.529 variant, commonly referred to as the Omicron variant, first reported from South Africa in November 2021.
According to the theoretical analysis of the N-protein sequence of the Omicron virus variant all mutation sites were outside of the target region identified by Mylab CoviSelf COVID-19 Rapid Antigen Self-test. This has now been confirmed by the study carried out by Center for Infection and Immunity, Columbia University Medical Center, using cultured Omicron virus as the CoviSelf COVID-19 Rapid Antigen test was able to detect Omicron cultured virus.
Dr Gautam Wankhede, Director of Medical Affairs at Mylab Discovery Solutions said, “We were confident that CoviSelf detects the Omicron variant of the virus and this study from one of the world’s most reputed universities adds more confidence. CoviSelf self-test kit is poised to play a central role in fighting the third wave not only in India, but worldwide.”
The self-testing kit, which was approved by ICMR last year, is experiencing a huge surge in demand as the cases in India increased by more than 10 times within 10 days. In countries like the US and UK, where the Omicron wave has hit, it has left the traditional testing infrastructure unable to meet demand and self-testing kits becoming the mainstream testing modality.